Publications2023-08-23T10:08:45-04:00

DFMO synergizes with BET inhibitors targeting ODC and MYCN to impede neuroblastoma cell proliferation and tumor initiation

Sarah DeCou, Ping Zhao, Tracey Avequin, Abhinav Nagulapally, Jeffrey Bond, Giselle Saulnier Sholler. DFMO synergizes with BET inhibitors targeting ODC and MYCN to impede neuroblastoma cell proliferation and tumor initiation, American Association[...]

Abstract|

The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment of Tumor Models in a Biology Study

Elizabeth VanSickle, Ping Zhao, Deanna Mitchell, Jess Foley, Julie Steinbrecher, Maria Rich, Abhinav Nagulapally, Jeff Bond, Will Hendricks, Giselle Saulnier Sholler. The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment[...]

Abstract|

BKM120 promotes apoptosis and suppresses tumor growth in medulloblastoma by targeting the phosphoinositide 3-kinase pathway

Zhao P, Hall J, Voydanoff A, Durston M, VanSickle E, Nagulapally AB, Bond J, Saulnier Sholler G, BKM120 promotes apoptosis and suppresses tumor growth in medulloblastoma by targeting the phosphoinositide 3-kinase[...]

Abstract|

DFMO Maintains Remission and Increases Overall Survival in High Risk Neuroblastoma: Results of a Phase II Prevention Trial

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis[...]

Abstract|

A Phase II Preventative Trial of DFMO in Patients with High Risk Neuroblastoma in Remission Prevents Relapse and Increases Overall Survival

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis[...]

Abstract|
Go to Top